Ist lavandula angustifolia flower oil in der Schwangerschaft sicher?
No EU Annex II/III listing or harmonised CLP classification was found (no H360/H361/H codes). Case reports and in vitro assays report estrogenic/anti‑androgenic activity linked to lavender oil components (Henley NEJM 2007; J Clin Endocrinol Metab review), but a well‑conducted in vivo uterotrophic percutaneous assay in immature rats found no estrogenic activity (Politano et al. 2013). Overall this places hazard at a low/theoretical level (h=1) with demonstrated in vitro mechanism evidence (m=2). Topical cosmetic exposure gives low but measurable systemic exposure (e=1). Sources: Henley 2007 (NEJM), J Clin Endocrinol Metab case series/assays, Politano 2013 uterotrophic negative, ECHA substance records, EWG entry.
Schwangerschaftssichere Alternativen zu lavandula angustifolia flower oil | VeriMom
Related ingredients
Frequently asked questions
- Ist lavandula angustifolia flower oil in der Schwangerschaft sicher?
- No EU Annex II/III listing or harmonised CLP classification was found (no H360/H361/H codes). Case reports and in vitro assays report estrogenic/anti‑androgenic activity linked to lavender oil components (Henley NEJM 2007; J Clin Endocrinol Metab review), but a well‑conducted in vivo uterotrophic percutaneous assay in immature rats found no estrogenic activity (Politano et al. 2013). Overall this places hazard at a low/theoretical level (h=1) with demonstrated in vitro mechanism evidence (m=2). Topical cosmetic exposure gives low but measurable systemic exposure (e=1). Sources: Henley 2007 (NEJM), J Clin Endocrinol Metab case series/assays, Politano 2013 uterotrophic negative, ECHA substance records, EWG entry.
- Ist lavandula angustifolia flower oil während des Stillens sicher?
- Same rationale as pregnancy: no harmonised classification or regulatory ban; mechanistic/in vitro signals exist but in vivo data do not confirm estrogenicity. Systemic absorption from topical use is low, so maternal exposure and transfer into breastmilk are possible but expected to be low from normal cosmetic use; therefore h=1, m=2, e=1.
- Ist lavandula angustifolia flower oil sicher für Babyhaut?
- Hazard remains low/theoretical (h=1) because human case reports/in vitro activity exist but no harmonised classification or conclusive animal reproductive/teratogenic evidence. Mechanistic signals (estrogenic/anti‑androgenic activity in vitro) are documented (m=2). Exposure score is increased by +1 for infants (immature skin barrier, higher surface-to-weight ratio) giving e=2 for baby topical exposure. Additionally, lavender oil constituents (oxidized linalool) are recognised contact allergens—relevance for infant skin sensitization is separate from reproductive scoring.
- Wie bewertet VeriMom lavandula angustifolia flower oil?
- VeriMom bewertet lavandula angustifolia flower oil mit 60/100 (mittleres Risiko) basierend auf EU CosIng, ECHA-Klassifizierungen und PubMed-Studien.
- Was sind schwangerschaftssichere Alternativen zu lavandula angustifolia flower oil?
- Siehe unsere kuratierte Liste der schwangerschaftssicheren Alternativen zu lavandula angustifolia flower oil basierend auf ähnlicher Funktion.
Prüfe jede Zutatenliste in 2 Sekunden
Lade VeriMom kostenlos — scanne jedes Produkt und sieh sofort die Schwangerschafts-Sicherheitsbewertung.
Medizinischer Haftungsausschluss
Diese Informationen dienen ausschließlich Bildungszwecken und stellen keine medizinische Beratung dar. Sicherheitsbewertungen basieren auf öffentlich zugänglichen Daten und spiegeln möglicherweise nicht alle Risiken wider. Konsultieren Sie immer Ihren Arzt, bevor Sie ein Produkt während der Schwangerschaft oder Stillzeit verwenden.